Evogene annual total assets
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Evogene Total Assets Growth & History (EVGN)
Evogene's total assets was $20.0M for fiscal 2025.
View full Evogene company overviewEvogene annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $20.0M | −$19.8M | −49.71% |
| 2024 | 2024-12-31 | $39.9M | −$11.2M | −21.99% |
| 2023 | 2023-12-31 | $51.1M | −$5.0M | −8.95% |
| 2022 | 2022-12-31 | $56.1M | −$20.2M | −26.44% |
| 2021 | 2021-12-31 | $76.3M | $4.4M | +6.10% |
| 2020 | 2020-12-31 | $71.9M | $551,000 | +0.77% |
| 2019 | 2019-12-31 | $71.4M | $12.7M | +21.59% |
| 2018 | 2018-12-31 | $58.7M | −$18.9M | −24.37% |
| 2017 | 2017-12-31 | $77.6M | −$18.4M | −19.15% |
| 2016 | 2016-12-31 | $96.0M | — | — |
Evogene quarterly total assets
Q4.16
Q4.17
Q4.18
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $13.4M | −$20.5M | −60.38% |
| Q1 2026 | 2026-03-31 | $17.9M | −$16.4M | −47.68% |
| Q4 2025 | 2025-12-31 | $20.0M | −$19.8M | −49.71% |
| Q3 2025 | 2025-09-30 | $26.1M | — | — |
| Q2 2025 | 2025-06-30 | $33.9M | −$7.0M | −17.19% |
| Q1 2025 | 2025-03-31 | $34.3M | — | — |
| Q4 2024 | 2024-12-31 | $39.9M | −$11.2M | −21.99% |
| Q2 2024 | 2024-06-30 | $41.0M | −$12.4M | −23.19% |
| Q4 2023 | 2023-12-31 | $51.1M | −$5.0M | −8.95% |
| Q2 2023 | 2023-06-30 | $53.3M | −$3.3M | −5.86% |
| Q4 2022 | 2022-12-31 | $56.1M | −$20.2M | −26.44% |
| Q2 2022 | 2022-06-30 | $56.7M | −$30.9M | −35.27% |
| Q4 2021 | 2021-12-31 | $76.3M | $4.4M | +6.10% |
| Q2 2021 | 2021-06-30 | $87.5M | $26.4M | +43.25% |
| Q4 2020 | 2020-12-31 | $71.9M | $551,000 | +0.77% |
| Q2 2020 | 2020-06-30 | $61.1M | — | — |
| Q4 2019 | 2019-12-31 | $71.4M | $12.7M | +21.59% |
| Q4 2018 | 2018-12-31 | $58.7M | −$18.9M | −24.37% |
| Q4 2017 | 2017-12-31 | $77.6M | −$18.4M | −19.15% |
| Q4 2016 | 2016-12-31 | $96.0M | — | — |
Evogene total assets trends
Over the last five fiscal years, Evogene's total assets decreased from $71.9M to $20.0M, a change of −$51.9M. The latest reported quarter, Q2 2026, shows $13.4M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Evogene source filings ↗